401 related articles for article (PubMed ID: 24876727)
21. Comparison of electroacupuncture and moxibustion on brain-gut function in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
Zhao JM; Lu JH; Yin XJ; Chen XK; Chen YH; Tang WJ; Jin XM; Wu LY; Bao CH; Wu HG; Shi Y
Chin J Integr Med; 2015 Nov; 21(11):855-65. PubMed ID: 25847778
[TBL] [Abstract][Full Text] [Related]
22. Development of Acupuncture and Moxibustion Protocol in a Clinical Trial for Irritable Bowel Syndrome.
Anastasi JK; Capili B; Chang M
J Acupunct Meridian Stud; 2017 Jan; 10(1):62-66. PubMed ID: 28254106
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in pharmacological treatment of irritable bowel syndrome.
Lazaraki G; Chatzimavroudis G; Katsinelos P
World J Gastroenterol; 2014 Jul; 20(27):8867-85. PubMed ID: 25083060
[TBL] [Abstract][Full Text] [Related]
24. Mild moxibustion for Irritable Bowel Syndrome with Diarrhea (IBS-D): A randomized controlled trial.
Wang Z; Xu M; Shi Z; Bao C; Liu H; Zhou C; Yan Y; Wang C; Li G; Zhang W; Gao A; Wu H
J Ethnopharmacol; 2022 May; 289():115064. PubMed ID: 35114338
[TBL] [Abstract][Full Text] [Related]
25. Acupuncture for irritable bowel syndrome: study protocol for a multicenter randomized controlled trial.
Pei LX; Geng H; Chen H; Wu XL; Chen L; Zhou JL; Ju L; Lu G; Xu WL; Qin S; Guo J; Yang EM; Sun JH
Trials; 2018 Oct; 19(1):529. PubMed ID: 30285891
[TBL] [Abstract][Full Text] [Related]
26. Irritable bowel syndrome: the role of gut neuroendocrine peptides.
El-Salhy M; Seim I; Chopin L; Gundersen D; Hatlebakk JG; Hausken T
Front Biosci (Elite Ed); 2012 Jun; 4(8):2783-800. PubMed ID: 22652678
[TBL] [Abstract][Full Text] [Related]
27. Irritable bowel syndrome and visceral hypersensitivity : risk factors and pathophysiological mechanisms.
Deiteren A; de Wit A; van der Linden L; De Man JG; Pelckmans PA; De Winter BY
Acta Gastroenterol Belg; 2016 Mar; 79(1):29-38. PubMed ID: 26852761
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the analgesic effects between electro-acupuncture and moxibustion with visceral hypersensitivity rats in irritable bowel syndrome.
Zhao JM; Li L; Chen L; Shi Y; Li YW; Shang HX; Wu LY; Weng ZJ; Bao CH; Wu HG
World J Gastroenterol; 2017 Apr; 23(16):2928-2939. PubMed ID: 28522910
[TBL] [Abstract][Full Text] [Related]
29. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.
Sinagra E; Morreale GC; Mohammadian G; Fusco G; Guarnotta V; Tomasello G; Cappello F; Rossi F; Amvrosiadis G; Raimondo D
World J Gastroenterol; 2017 Sep; 23(36):6593-6627. PubMed ID: 29085207
[TBL] [Abstract][Full Text] [Related]
30. Functional findings in irritable bowel syndrome.
Posserud I; Ersryd A; Simrén M
World J Gastroenterol; 2006 May; 12(18):2830-8. PubMed ID: 16718806
[TBL] [Abstract][Full Text] [Related]
31. The efficacy and neural mechanism of acupuncture therapy in the treatment of visceral hypersensitivity in irritable bowel syndrome.
Yang Y; Wang J; Zhang C; Guo Y; Zhao M; Zhang M; Li Z; Gao F; Luo Y; Wang Y; Cao J; Du M; Wang Y; Lin X; Xu Z
Front Neurosci; 2023; 17():1251470. PubMed ID: 37732301
[TBL] [Abstract][Full Text] [Related]
32. Electro-acupuncture for irritable bowel syndrome patients: study protocol for a single-blinded randomized sham-controlled clinical trial.
Zhong LLD; Lam TF; Yang W; Zheng Y; Lyu Z; Bian Z
Trials; 2021 Sep; 22(1):619. PubMed ID: 34526079
[TBL] [Abstract][Full Text] [Related]
33. [Research advances in the mechanism of acupuncture and moxibustion in regulating gastrointestinal motility and related thinking].
Wang WY; Liang FX; Chen R
Zhen Ci Yan Jiu; 2020 Sep; 45(9):771-5. PubMed ID: 32959563
[TBL] [Abstract][Full Text] [Related]
34. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Harris LA; Baffy N
Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
[TBL] [Abstract][Full Text] [Related]
35. Irritable bowel syndrome: emerging paradigm in pathophysiology.
Lee YJ; Park KS
World J Gastroenterol; 2014 Mar; 20(10):2456-69. PubMed ID: 24627583
[TBL] [Abstract][Full Text] [Related]
36. Multi-target Treatment for Irritable Bowel Syndrome with STW 5: Pharmacological Modes of Action.
Allescher HD; Burgell R; Malfertheiner P; Mearin F
J Gastrointestin Liver Dis; 2020 Jun; 29(2):227-233. PubMed ID: 32530990
[TBL] [Abstract][Full Text] [Related]
37. Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment.
Chang JY; Talley NJ
Trends Pharmacol Sci; 2010 Jul; 31(7):326-34. PubMed ID: 20554042
[TBL] [Abstract][Full Text] [Related]
38. A review of neuroendocrine immune system abnormalities in IBS based on the brain-gut axis and research progress of acupuncture intervention.
Sun Z; Wang X; Feng S; Xie C; Xing Y; Guo L; Zhao J; Ji C
Front Neurosci; 2023; 17():934341. PubMed ID: 36968497
[TBL] [Abstract][Full Text] [Related]
39. Impact of psychological stress on irritable bowel syndrome.
Qin HY; Cheng CW; Tang XD; Bian ZX
World J Gastroenterol; 2014 Oct; 20(39):14126-31. PubMed ID: 25339801
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome.
Zhang Y; Qin G; Liu DR; Wang Y; Yao SK
World J Gastroenterol; 2019 Jan; 25(2):269-281. PubMed ID: 30670915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
